Rating History for ARS Pharmaceuticals Inc (SPRY) by Northland

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/9/2026 Carl Byrnes Jr. New Coverage Outperform
(N/A)
25.00
(N/A)
8.19
(9.98)
21.86% Details